Atypicals for Non-psychotic disorders
The Carlat Psychiatry Report, Volume 7, Number 3, March 2009
Heidi W. Ashih, MD, PhD
You may have noticed a recent torrent of FDA approvals and clinical trials for atypical antipsychotics in every disorder under the sun–except psychosis. Is this simply an effort by the sponsoring companies to get us to prescribe more antipsychotics? Or are these drugs truly effective for non-psychotic disorders? What’s the quality of the evidence?
Heidi W. Ashih, MD
Psychiatry Resident, Cambridge Health Alliance, Clinical Fellow in Psychiatry, Harvard Medical School
Dr. Ashih reports no financial relationships with any commercial companies related to this article